Long-term Extension Study of BEMA™ Fentanyl

Mise à jour : Il y a 4 ans
Référence : NCT00696137

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is designed to provide continued access to BEMA Fentanyl for those subjects who previously participated in FEN-202 and who wish to continue using BEMA Fentanyl for the treatment of their breakthrough cancer pain.


Critère d'inclusion

  • Cancer,pain

Liens